Share capital [Text Block] | 6. Share capital Authorized: unlimited common shares, no par value Ascribed value Number of shares $ November 30, 2015 104,796,421 136,040 Exercise of options 162,854 65 Restricted Share Units 108,399 34 Deferred Share Units 218,795 218 November 30, 2016 105,286,469 136,357 Exercise of options 58,822 23 Restricted Share Units 209,198 83 May 31, 2017, issued and outstanding 105,554,489 136,463 On April 30, 2012, under the NovaGold Arrangement, Trilogy committed to issue common shares, once vested, to satisfy holders of deferred share units (“NovaGold DSUs”) on record as of the close of business April 27, 2012. When vested, Trilogy committed to deliver one Common Share to the holder for every six shares of NovaGold the holder is entitled to receive, rounded down to the nearest whole number. As of May 31, 2017, 20,685 3,447 (a) Stock options During the period ended May 31, 2017, 1,695,000 1,785,000 0.72 0.44 0.22 For the six month period ended May 31, 2017, Trilogy recognized a stock-based compensation charge of $ 0.27 0.25 The fair value of the stock options recognized in the period has been estimated using the Black-Scholes option pricing model. Assumptions used in the pricing model for the period are as provided below. May 31, 2017 Risk-free interest rates 0.89 % Exercise price CDN$0.72 Expected life 3.0 years Expected volatility 74.3 % Expected dividends Nil As of May 31, 2017, there were 1,405,843 0.45 0.1 May 31, 2017 Weighted average exercise price Number of options $ Balance beginning of period 6,049,433 0.50 Granted 1,695,000 0.53 Exercised (175,938) 0.34 Forfeited (149,169) 0.41 Balance end of period 7,419,326 0.51 Outstanding Exercisable Unvested Weighted Weighted Weighted average average Number of average exercise Number of exercise Number of Range of outstanding years to price exercisable price unvested price options expiry $ options $ options $0.33 to $0.50 4,427,660 3.21 0.38 3,748,490 0.39 679,170 $0.51 to $1.00 2,936,666 3.55 0.69 2,209,993 0.75 726,673 $1.01 to $1.47 55,000 0.92 1.47 55,000 1.47 - 7,419,326 3.33 0.51 6,013,483 0.53 1,405,843 The aggregate intrinsic value of vested share options (the market value less the exercise price) at May 31, 2017 was $ 1.2 0.78 0.03 0.03 (b) NovaGold Arrangement Options Under the NovaGold Arrangement, holders of NovaGold stock options received one option in Trilogy for every six options held in NovaGold (“NovaGold Arrangement Options”). All NovaGold Arrangement Options remaining expired during the six months ended May 31, 2017. May 31, 2017 Weighted average exercise price Number of options $ Balance beginning of period 312,195 4.26 Expired (312,195) 4.26 Balance end of period - - (c) Restricted Share Units and Deferred Share Units The Company has a Restricted Share Unit Plan (“RSU Plan”) and a Non-Executive Director Deferred Share Unit Plan (“DSU Plan”) to provide long-term incentives to employees, officers and directors. The RSU Plan and DSU Plan may be settled in cash and/or Common Shares at the Company’s election with each RSU and DSU entitling the holder to receive one common share of the Company or equivalent value. All units are accounted for as equity-settled awards. Number of RSUs Number of DSUs Balance beginning of period 400,001 925,390 Granted 600,000 72,241 Vested/paid (399,999) - Balance end of period 600,002 997,631 For the six months ended May 31, 2017, Trilogy recognized a stock-based compensation charge of $ 0.30 0.15 On December 15, 2016, 600,000 399,999 209,198 90,000 (d) Share Purchase Warrants Weighted Weighted average exercise Number of average years to price Warrants expiry $ Balance beginning of period 6,521,740 2.35 1.60 Balance end of period 6,521,740 2.35 1.60 |